Laura Brege Acadia Pharmaceuticals Inc (ACAD) insider trading activity

Laura Brege is of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 20,154 shares of ACAD, which is worth approximately $311,983. The most recent transaction as insider was on May 29, 2024, when has been sold 6,652 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.2K

0% 3M change

49.27% 12M change

Total Value Held $311,983

Laura Brege Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2024	BUY Exercise of conversion of derivative security	-	6,652 Added 24.82%	20,154 Common Stock
Jun 12 2023	SELL Open market or private sale	$111,915 $24.87 p/Share	4,500 Reduced 25.0%	13,502 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	-	8,552 Added 32.21%	18,002 Common Stock
Jan 12 2023	SELL Open market or private sale	$228,125 $18.25 p/Share	12,500 Reduced 100.0%	0 Common Stock
Jan 12 2023	BUY Exercise of conversion of derivative security	$212,625 $17.01 p/Share	12,500 Added 50.0%	12,500 Common Stock
Jun 07 2022	BUY Exercise of conversion of derivative security	-	6,391 Added 40.34%	9,450 Common Stock
Jun 22 2021	BUY Exercise of conversion of derivative security	-	3,059 Added 50.0%	3,059 Common Stock

Also insider at

PCRX

Pacira BioSciences, Inc. Healthcare

Director

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

EWTX

Edgewise Therapeutics, Inc. Healthcare

Laura Brege

Tampa, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Value

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

Operation

Value

Type

News

Receive news related to ACADIA PHARMACEUTICALS INC

Track Activities on ACAD

Account